Katherine R Tuttle Selected Research

Proteinuria

1/2023	Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study.
1/2021	Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies.
8/2020	The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study Network.
1/2016	Complete Remission in the Nephrotic Syndrome Study Network.
3/2015	Serum amyloid A and inflammation in diabetic kidney disease and podocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katherine R Tuttle Research Topics

Disease

47	Chronic Renal Insufficiency 04/2024 - 11/2006
45	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2005
43	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 07/2003
30	Albuminuria 03/2024 - 01/2005
25	Kidney Diseases (Kidney Disease) 05/2024 - 01/2005
23	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 06/2003
13	Hypertension (High Blood Pressure) 01/2024 - 06/2003
13	Inflammation (Inflammations) 12/2023 - 04/2005
12	Chronic Kidney Failure (Chronic Renal Failure) 04/2024 - 01/2012
11	Renal Insufficiency (Renal Failure) 10/2023 - 01/2005
10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024 - 01/2002
9	Heart Failure 12/2023 - 01/2014
9	Fibrosis (Cirrhosis) 06/2023 - 03/2005
9	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 10/2014
8	Obesity 12/2022 - 12/2005
7	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2003
7	Myocardial Infarction 12/2022 - 01/2005
6	Body Weight (Weight, Body) 01/2023 - 09/2011
6	Renal Artery Obstruction (Renal Artery Stenosis) 01/2019 - 01/2014
5	Weight Loss (Weight Reduction) 11/2023 - 12/2022
5	Proteinuria 01/2023 - 03/2015
5	Dyslipidemias (Dyslipidemia) 10/2022 - 03/2010
4	Hyperglycemia 04/2024 - 01/2022
4	Infections 04/2024 - 12/2017
4	Diabetes Mellitus 04/2024 - 09/2007
4	Disease Progression 12/2023 - 04/2020
4	Stroke (Strokes) 11/2022 - 01/2005
3	Insulin Resistance 04/2024 - 12/2005
3	Anemia 12/2023 - 03/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2023 - 12/2005
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2023 - 08/2020
3	Atherosclerosis 12/2022 - 11/2004
3	Isolated Systolic Hypertension 01/2016 - 03/2006
3	Hyperuricemia 03/2006 - 06/2003
2	COVID-19 08/2023 - 01/2022
2	Hyperkalemia 03/2023 - 01/2022
2	Overweight 01/2023 - 09/2011
2	Prediabetic State (Prediabetes) 12/2022 - 10/2022
2	Ketosis 01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

24	CreatinineIBA 12/2023 - 11/2005
19	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 03/2006
16	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2024 - 01/2018
12	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2012
12	AlbuminsIBA 12/2023 - 11/2005
9	Uric Acid (Urate)IBA 01/2023 - 06/2003
8	Insulin Glargine (Lantus)FDA Link 01/2023 - 05/2014
7	Sodium-Glucose Transport ProteinsIBA 12/2022 - 01/2019
7	ruboxistaurinIBA 04/2015 - 04/2005
7	Protein Kinase C betaIBA 11/2008 - 09/2003
6	Glucagon-Like Peptide-1 Receptor AgonistsIBA 06/2023 - 12/2018
6	CholesterolIBA 01/2023 - 01/2005
6	Insulin (Novolin)FDA Link 01/2023 - 03/2006
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 09/2007
6	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 11/2007
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2024 - 01/2017
5	SodiumIBA 01/2024 - 01/2018
5	dulaglutideIBA 01/2023 - 01/2017
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 08/2017
5	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2019 - 03/2015
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2005
4	Mineralocorticoid Receptor AntagonistsIBA 01/2024 - 01/2022
4	empagliflozinIBA 12/2023 - 01/2022
4	IncretinsIBA 01/2023 - 01/2019
4	Allopurinol (Remid)FDA LinkGeneric 11/2022 - 03/2006
4	Angiotensin Receptor AntagonistsIBA 01/2018 - 09/2007
3	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 03/2024 - 12/2023
3	Serum AlbuminIBA 01/2024 - 08/2020
3	tirzepatideIBA 01/2023 - 11/2022
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 10/2014
3	Cystatin CIBA 01/2019 - 01/2016
3	Advanced Glycation End ProductsIBA 03/2014 - 11/2010
3	Amino Acids FDA Link 07/2013 - 01/2002
2	AldosteroneIBA 03/2024 - 12/2023
2	C-Reactive ProteinIBA 12/2023 - 09/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2023 - 11/2022
2	finerenoneIBA 10/2023 - 03/2023
2	semaglutideIBA 06/2023 - 01/2023
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2021
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 10/2022
2	Glucagon (Glukagon)FDA Link 01/2023 - 01/2002
2	SymportersIBA 01/2023 - 01/2018
2	Janus KinasesIBA 11/2018 - 03/2014
2	MineralsIBA 01/2018 - 03/2010
2	HDL CholesterolIBA 01/2018 - 01/2016
2	Messenger RNA (mRNA)IBA 03/2015 - 03/2005
2	ReninIBA 07/2014 - 01/2009
2	Exenatide (Byetta)FDA Link 05/2014 - 08/2013
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2007 - 04/2007

Therapy/Procedure

48	Therapeutics 05/2024 - 09/2003
6	Glycemic Control 01/2023 - 09/2008
5	Drug Therapy (Chemotherapy) 10/2022 - 10/2014
4	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2022 - 01/2014
3	Renal Dialysis (Hemodialysis) 01/2024 - 10/2020
3	Bariatric Surgery 12/2022 - 10/2022
3	High-Protein Diet 07/2013 - 07/2003
2	Obesity Management 12/2022 - 12/2022
2	Surgical Amputation (Amputations) 01/2022 - 01/2005
2	Precision Medicine 01/2021 - 01/2021
2	Stents 11/2016 - 12/2015
2	Mediterranean Diet 09/2011 - 07/2006